OBJECTIVES: Upon completion of this activity, the participant should be able to:
1.  Discuss and differentiate the clinical presentation, diagnostic features, and subtypes of spasmodic dysphonia (adductor, abductor, and mixed) from essential vocal tremor and other neurogenic voice disorders.
2.  Describe the mechanism of action, patient selection criteria, injection techniques, and expected outcomes of botulinum toxin therapy for spasmodic dysphonia and vocal tremor.
3.  Review and formulate an evidence-based treatment plan for patients with neurogenic voice disorders that integrates botulinum toxin injections with voice therapy, medical optimization, and surgical options when appropriate.

FACULTY DISCLOSURE: Randall Holdgraf, MD has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact [email protected]

MEETING LINK: